SCHEMBL20726267

SCHEMBL20726267

CCCCN(C)C(CO)[C@@H](O)[C@@H](C)O

nearest known ligand 0.37

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
▸ SPHK2 Q9NRA0 2/20 0.37
▸ SPHK1 Q9NYA1 2/20 0.37
▸ CETP P11597 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9400807 0.73 SPHK1 (0.38) SPHK2SPHK1CETP
SCHEMBL7775347 0.73 ALDH1A1 (0.37) —
SCHEMBL1040028 0.72 — —
SCHEMBL2975409 0.71 — —
SCHEMBL17888811 0.69 TDP1 (0.35) —
SCHEMBL19092286 0.68 SPHK2 (0.33) SPHK2SPHK1CETP
SCHEMBL18938554 0.67 DNM1 (0.48) SPHK1
SCHEMBL21021570 0.67 ALDH1A1 (0.33) SPHK2SPHK1CETP
SCHEMBL18849897 0.67 DNM1 (0.32) —
SCHEMBL18938552 0.67 DNM1 (0.48) SPHK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3782655-A1 A METHOD FOR THE TREATMENT OF POMPE DISEASE USING 1-DEOXYNOJIRIMYCIN AND DERIVATIVES Amicus Therapeutics, Inc. (US) 2021-02-24 — — EP disclosed
EP-3441090-A1 A METHOD FOR THE TREATMENT OF POMPE DISEASE USING 1-DEOXYNOJIRIMYCIN AND DERIVATIVES Amicus Therapeutics, Inc. (US) 2019-02-13 — — EP disclosed
Send feedback